Literature DB >> 19122516

Celiac disease.

Carlo Catassi1, Alessio Fasano.   

Abstract

PURPOSE OF REVIEW: Recent advances in the clinical, epidemiological, genetic, and therapeutic aspects of celiac disease have made this condition a superb model of autoimmunity. This review will outline the most significant work that contributed to our current knowledge of the disease. RECENT
FINDINGS: Celiac disease is not confined to the Caucasian population as previously believed; rather its prevalence is approximately 1% worldwide. In addition to the HLA genes, many other genes involved in innate and adaptive immunity, intestinal barrier regulation, and autoimmunity have been identified as integral genetic components of the disease. Based on this information and on a better understanding of celiac disease pathogenesis, novel therapies alternative to the gluten-free diet are currently in advanced phase of development.
SUMMARY: The outcome of these new findings will most likely have a significant impact in clinical practice, including diagnosis and management of the disease. Furthermore, celiac disease can be used as a unique model to gain more insights on the pathogenesis of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19122516     DOI: 10.1097/MOG.0b013e32830edc1e

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  35 in total

1.  What do Brazilian pediatricians know about celiac disease?

Authors:  Camilo Vieira; Marília Matos; Thaise Quaresma; Juliana de Oliveira; Cibele Dantas Ferreira; Adriza Silva; Daniel Diniz-Santos; Luciana R Silva
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

Review 2.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

Review 4.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

5.  Germination of oat and quinoa and evaluation of the malts as gluten free baking ingredients.

Authors:  Outi E Mäkinen; Emanuele Zannini; Elke K Arendt
Journal:  Plant Foods Hum Nutr       Date:  2013-03       Impact factor: 3.921

Review 6.  A short review of malabsorption and anemia.

Authors:  Fernando Fernández-Bañares; Helena Monzón; Montserrat Forné
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

7.  Diagnosis and treatment of coeliac disease.

Authors:  Karel Geboes; Karen P Geboes
Journal:  F1000 Med Rep       Date:  2009-04-29

8.  Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.

Authors:  Anna Sapone; Karen M Lammers; Giuseppe Mazzarella; Irina Mikhailenko; Maria Cartenì; Vincenzo Casolaro; Alessio Fasano
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

9.  A Brazilian experience of the self transglutaminase-based test for celiac disease case finding and diet monitoring.

Authors:  Lorete Maria da Silva Kotze; Ana Paula Brambila Rodrigues; Luiz Roberto Kotze; Renato Mitsunori Nisihara
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

10.  Emerging analytical methods to determine gluten markers in processed foods--method development in support of standard setting.

Authors:  Dorcas Weber; Chantal Cléroux; Samuel Benrejeb Godefroy
Journal:  Anal Bioanal Chem       Date:  2009-07-28       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.